My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 199

    1.

    CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.

    Einarsdóttir K, Rylander-Rudqvist T, Humphreys K, Ahlberg S, Jonasdottir G, Weiderpass E, Chia KS, Ingelman-Sundberg M, Persson I, Liu J, Hall P, Wedrén S.

    Breast Cancer Res. 2005;7(6):R890-6. Epub 2005 Sep 14.PMID: 16280037 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.

    Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB.

    Breast Cancer Res. 2005;7(4):R513-21. Epub 2005 May 12.PMID: 15987458 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.

    Verla-Tebit E, Wang-Gohrke S, Chang-Claude J.

    Breast Cancer Res. 2005;7(4):R455-64. Epub 2005 Apr 12.PMID: 15987450 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Genetic polymorphism of CYP17 and breast cancer risk in Korean women.

    Shin MH, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY, Park SK, Noh DY, Ahn SH, Kim B, Kang D.

    Exp Mol Med. 2005 Feb 28;37(1):11-7.PMID: 15761247 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

    Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

    Breast Cancer Res Treat. 2009 Mar;114(2):327-38. Epub 2008 Jul 16.PMID: 18629629 [PubMed - indexed for MEDLINE]Related articles

    6.

    The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.

    Ye Z, Parry JM.

    Mutagenesis. 2002 Mar;17(2):119-26.PMID: 11880540 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.

    Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, Giles GG, Southey MC, Venter DJ, Easton DF, Chenevix-Trench G.

    J Natl Cancer Inst. 2000 Oct 18;92(20):1674-81.PMID: 11036113 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.

    Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.

    Cancer Res. 1999 Mar 1;59(5):1015-20.PMID: 10070957 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors.

    Ambrosone CB, Moysich KB, Furberg H, Freudenheim JL, Bowman ED, Ahmed S, Graham S, Vena JE, Shields PG.

    Breast Cancer Res. 2003;5(2):R45-51. Epub 2003 Jan 29.PMID: 12631398 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    A polymorphism in the CYP17 gene increases the risk of breast cancer.

    Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE.

    Cancer Res. 1997 Mar 15;57(6):1063-5.PMID: 9067272 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

    Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A.

    Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8.PMID: 11142420 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.

    Chakraborty A, Murthy NS, Chintamani C, Bhatnagar D, Mohil RS, Sharma PC, Saxena S.

    J Hum Genet. 2007;52(2):159-65. Epub 2007 Jan 18.PMID: 17235448 [PubMed - indexed for MEDLINE]Related articles

    13.

    CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

    Setiawan VW, Schumacher FR, Haiman CA, Stram DO, Albanes D, Altshuler D, Berglund G, Buring J, Calle EE, Clavel-Chapelon F, Cox DG, Gaziano JM, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn J, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Kraft P, Ma J, Le Marchand L, Linseisen J, Lund E, Navarro C, Overvad K, Palli D, Peeters PH, Pike MC, Riboli E, Stampfer MJ, Thun MJ, Travis R, Trichopoulos D, Yeager M, Ziegler RG, Spencer Feigelson H, Chanock SJ.

    Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2237-46.PMID: 18006912 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A polymorphism in CYP17 and endometrial cancer risk.

    Haiman CA, Hankinson SE, Colditz GA, Hunter DJ, De Vivo I.

    Cancer Res. 2001 May 15;61(10):3955-60.PMID: 11358812 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.

    Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY.

    Cancer Res. 1999 Oct 1;59(19):4870-5.PMID: 10519398 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Genetic polymorphism in CYP17 and breast cancer risk in Japanese women.

    Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S.

    Eur J Cancer. 2000 Dec;36(18):2375-9.PMID: 11094312 [PubMed - indexed for MEDLINE]Related articles

    17.

    No association of the 5' promoter region polymorphism of CYP17 with breast cancer risk in Japan.

    Hamajima N, Iwata H, Obata Y, Matsuo K, Mizutani M, Iwase T, Miura S, Okuma K, Ohashi K, Tajima K.

    Jpn J Cancer Res. 2000 Sep;91(9):880-5.PMID: 11011114 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association between CYP17 gene polymorphism and risk of breast cancer in young women.

    Bergman-Jungeström M, Gentile M, Lundin AC, Wingren S.

    Int J Cancer. 1999 Aug 20;84(4):350-3.PMID: 10404084 [PubMed - indexed for MEDLINE]Related articles

    19.

    Association between CYP17 polymorphisms and the development of breast cancer.

    Helzlsouer KJ, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Comstock GW, Bell DA.

    Cancer Epidemiol Biomarkers Prev. 1998 Oct;7(10):945-9.PMID: 9796641 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Estrogen-biosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island Breast Cancer Study Project.

    Chen Y, Gammon MD, Teitelbaum SL, Britton JA, Terry MB, Shantakumar S, Eng SM, Wang Q, Gurvich I, Neugut AI, Santella RM, Ahsan H.

    Carcinogenesis. 2008 Apr;29(4):766-71. Epub 2008 Feb 14.PMID: 18281250 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk